4
Changes in Ownership
BioAge Labs, Inc. Filed Acc 0001415889-25-004857
Options or other derivatives
- Chief Executive Officer acquired 530,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Fortney Kristen · Chief Executive Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-02-18 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +530,000 | 530,000 | D |
Loading xslF345X05/form4-02202025_090259.xml…